mesowatch
HomeResearchers Use AI to Triage Patients With Chest Pain
divider

Researchers Use AI to Triage Patients With Chest Pain

AI use in medical field

Cutting-edge artificial intelligence (AI) technology has the potential to revolutionize care for patients presenting with acute chest pain, according to a groundbreaking study published in Radiology, a journal of the Radiological Society of North America (RSNA). 

Led by Dr. Márton Kolossváry, the study introduces a deep learning AI model capable of identifying individuals among acute chest pain patients who require immediate medical attention, marking a significant advancement in emergency medicine.

The Role of Deep Learning AI in Triage

Acute chest pain syndrome, characterized by various discomforts in the chest region, is a common reason for emergency department visits, with over 7 million cases reported annually in the United States alone. Despite its prevalence, accurately identifying patients at risk for life-threatening conditions such as acute coronary syndrome, pulmonary embolism, or aortic dissection remains challenging. Conventional diagnostic methods often lead to unnecessary imaging and testing, exacerbating the strain on emergency department resources.

Utilizing chest X-ray images, the research team developed an innovative deep learning model to predict adverse outcomes, including acute coronary syndrome, pulmonary embolism, aortic dissection, or all-cause mortality, within 30 days. Trained on electronic health records of over 5,000 patients, the AI model demonstrated superior predictive capabilities compared to traditional clinical markers, such as age, sex, and biomarker data.

Enhanced Diagnostic Accuracy and Patient Triage

The deep-learning tool significantly enhanced the accuracy of outcome prediction, enabling more precise patient triage in the emergency department. By analyzing chest X-ray images, the AI model identified individuals at high risk, facilitating timely interventions and potentially reducing unnecessary testing for low-risk patients. Notably, the model’s performance remained consistent across demographic factors such as age, sex, ethnicity, and race.

Dr. Kolossváry envisions the integration of this automated AI model into routine emergency department workflows, empowering clinicians to make informed decisions regarding patient care. By leveraging the predictive capabilities of deep learning technology, healthcare providers can optimize resource allocation, streamline patient management, and improve overall outcomes for acute chest pain patients.

The study underscores the transformative potential of AI in emergency medicine, offering a glimpse into a future where advanced technology enhances clinical decision-making and improves patient outcomes. With further refinement and validation, AI-driven solutions like the one presented in this study hold promise for revolutionizing patient care and shaping the future of healthcare delivery.

Amna Anees

Reading Time: 1 mins

Published On: January 17, 2023

Amna Anees - author

Amna is a molecular biologist and has a deep interest in the field of health and medicine. She has worked in the field of proteomics and plants molecular biology. Being a biologist herself, she has developed an interest in the field of therapeutic studies of mesothelioma and related researches.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer